16 Oct Fujifilm Filed an Application for Partial Changes to the Manufacturing and Marketing Approval Matters of Anti-Influenza Drug Avigan® Tablet in Japan to Include Additional Indication for COVID-19

Fujifilm Filed an Application for Partial Changes to the Manufacturing and Marketing Approval Matters of Anti-Influenza Drug Avigan® Tablet in Japan to Include Additional Indication for COVID-19 posted on FujiFilm.com on .

Read the full article on FujiFilm.com
Home




Notice: Undefined variable: qode_like in /sites/fujixnews.com/public/wp-content/themes/bridge/templates/blog-parts/blog-share-like-below-text.php on line 10